Articles Tagged With:
-
A Possible New Treatment for HTLV-1-associated Myelopathy
Mogamulizumab reduces central nervous system inflammation and improves spasticity in patients with HTLV-1-associated myelopathy.
-
Parsonage-Turner Syndrome: Where’s the Lesion?
SYNOPSIS: This careful analysis of MRI imaging of the brachial plexus in patients with well-defined Parsonage-Turner Syndrome showed that the lesions are in peripheral branches of the brachial plexus and not in the roots or cords.
-
Lessons Learned From a Failed Anti-amyloid Trial for Alzheimer’s Disease
Despite the disappointing results in EXPEDITION 3, modifications of clinical trials for Alzheimer’s disease (AD) should be undertaken and trials targeting preclinical or early AD should continue with anti-amyloid agents.
-
Postpartum Headache May Be a Symptom of a Serious Problem
Consultation for acute postpartum headache resulted in the diagnosis of a secondary cause of headache in almost three out of four women, with almost half of the secondary headaches due to a hypertensive disorder of pregnancy or to cerebrovascular disease.
-
Coprescription of Triptans and SSRI-type Medications and the Serotonin Syndrome
A recent study provided reassurance that the use of triptan antimigraine medications with selective serotonin reuptake inhibitor and selective norepinephrine reuptake inhibitor antidepressants is safe.
-
Autoimmune Encephalitis: Not Rare and Increasing
Detection of autoimmune encephalitis is increasing over time. According to the results from this population-based study, its prevalence and incidence are comparable to infectious encephalitis.
-
Negligent Presurgery Procedure Results in Fatal Pulmonary Arrest, $5.5 Million Verdict
This case illustrates the need for communication in the healthcare industry. In this case, a breakdown in communication occurred interhospital, intrahospital, and between patient and medical professional.
-
Physician on Probation Places Patient in Unnecessary Coma, Yielding $9 Million Verdict
The patient was left untreated for a month before a second opinion was obtained.
-
Hospital and Cardiology Group to Pay $20.75 Million
A Pennsylvania hospital and cardiology group have agreed to pay the government $20.75 million to settle a False Claims Act lawsuit alleging that they knowingly submitted claims to the Medicare and Medicaid programs that violated the Anti-Kickback Statute and the Physician Self-Referral Law.
-
$3.5 Million Settlement Highlights Risk Analysis
A health system’s recent settlement with the government shows how providers still are dropping the ball on compliance issues that everyone should understand by now.